Portal de investigación
- Inicio
- Proyectos y Estudios
- ESTUDIO ALEATORIO, DOBLE CIEGO, MULTICENTRICO CON CONTROL ACTIVO PARA EVALUAR LA REDUCCION DEL C-LDL PRODUCIDA POR EL CAMBIO A UN COMPRIMIDO CON LA COMBINACION DE EZETIMIBA/SIMVASTATINA (10 MG/20 MG) EN COMPARACION CON EL AUMENTO AL DOBLE DE LA DOSIS DE ATORVASTATINA DE 10 MG A 20 MG, EN PACIENTES CON HIPERCOLESTEROLEMIA Y ATEROSCLEROSIS O ENFERMEDADES CORONARIAS.
ESTUDIO ALEATORIO, DOBLE CIEGO, MULTICENTRICO CON CONTROL ACTIVO PARA EVALUAR LA REDUCCION DEL C-LDL PRODUCIDA POR EL CAMBIO A UN COMPRIMIDO CON LA COMBINACION DE EZETIMIBA/SIMVASTATINA (10 MG/20 MG) EN COMPARACION CON EL AUMENTO AL DOBLE DE LA DOSIS DE ATORVASTATINA DE 10 MG A 20 MG, EN PACIENTES CON HIPERCOLESTEROLEMIA Y ATEROSCLEROSIS O ENFERMEDADES CORONARIAS.
Datos básicos
- Protocolo:
- MSD653-806
- EUDRACT:
- NO ENCUENTRO
- NCT:
- Centro:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[[en]]Peripheral access ultrafiltration in adults with complex congenital heart disease and refractory congestion.
Guerrero Cervera B; (...); Almenar Bonet L
Article. 10.1016/j.rec.2024.08.015. 2024
An atypical complication of a patent foramen ovale closure device in an adult: Late infective endocarditis
Echeverria, PMB; (...); Martinez-Leon, J
Article. 10.1016/j.circv.2020.10.007. 2021
CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Correction. 10.1016/j.rec.2023.03.018. 2023
CA125: a new biomarker in patients with Fontan circulation.
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Article. 10.1016/j.rec.2022.05.029. 2022
Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker.
Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis
Article. 10.3390/jpm12060913. 2022
COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG
Trenado, VD; (...); Almenar-Bonet, L
Meeting Abstract. 2021
Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis.
Galian-Gay, Laura; (...); Evangelista, Artur
Article. 10.1093/ehjci/jead067. 2023
Decreased clinical performance in TGA-ASO patients after RVOT interventions; a multicenter European collaboration.
Engele LJ; (...); Bouma BJ
Article. 10.1016/j.ijcard.2024.132027. 2024
Decreased clinical performance in TGA-ASO patients after RVOT re-interventions; multicenter European collaboration
Engele, L.; (...); Bouma, B. J.
Meeting Abstract. 2023
Eisenmenger syndrome: is it the same entity in adulthood and pediatric age?
Playan Escribano, J.; (...); Del Cerro Marin, M. J.
Meeting Abstract. 2021
Epidemiology of supplemental oxygen in patients with pulmonary hypertension.
Torres-Castro, Rodrigo; (...); Blanco, Isabel
Article. 10.1111/resp.14821. 2024
ESTIMATION OF THE ECONOMIC AND SOCIAL BURDEN OF PULMONARY ARTERIAL HYPERTENSION IN SPAIN
Zozaya, N.; (...); Hidalgo Vega, A.
Meeting Abstract. 2022
Evolutionary description of heart transplantation and heart-lung transplantation in congenital heart disease
Donoso Trenado, V.; (...); Almenar Bonet, L.
Meeting Abstract. 2022
Evolutionary Description of Heart Transplantation and Heart-Lung Transplantation in Congenital Heart Disease.
Donoso Trenado, Victor; (...); Almenar-Bonet, Luis
Article. 10.1016/j.transproceed.2022.10.006. 2022
Heart transplantation and heart-lung transplantation in congenital heart disease. experience in a tertiary referral hospital
Donoso, V.; (...); Almenar Bonet, L.
Meeting Abstract. 2021
Lack of agreement between the exercise variables to assess the risk in PAH
Martinez Menaca, Amaya; (...); Escribano Subias, Pliar
Meeting Abstract. 10.1183/13993003.congress-2021.OA142. 2021
Left atrial strain in adults after the arterial switch operation for transposition of the great arteries.
Buendia-Fuentes, Francisco; (...); Rueda, Joaquin
Article. 10.1111/echo.15750. 2024
Left ventricular systolic performance in adults after arterial switch operation. Echocardiographic data from EPOCH-ASO: a multi-centric international registry
Fernandez, V. Gonzalez; (...); Dos, L.
Meeting Abstract. 2023
Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.
Lozano-Edo S; (...); Martínez-Dolz L
Article. 10.1097/TP.0000000000003798. 2021
Pulmonary arterial hypertension associated with pretricuspid shunts: risk profile and survival.
Calvo-Asensio, Maria; (...); Rueda Soriano, Joaquin
Article. 10.1016/j.rec.2024.04.016. 2024
Rationale and design of the rigorous atrial analysis in advanced interatrial block (ARABIA) prospective study
Martinez-Selles, M; (...); Perez-David, E
Article. 10.1016/j.jelectrocard.2021.08.007. 2021
Safety and feasibility of conduction system pacing in patients with congenital heart disease
Cano, O; (...); Vijayaraman, P
Article. 10.1111/jce.15213. 2021
The coronavirus disease pandemic among adult congenital heart disease patients and the lessons learnt - results of a prospective multicenter european registry.
Ruperti-Repilado, Francisco Javier; (...); Schwerzmann, Markus
Article. 10.1016/j.ijcchd.2022.100428. 2023
The economic burden of pulmonary arterial hypertension in Spain.
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.1186/s12890-022-01906-2. 2022
Univentricular hearts not undergoing Fontan: the type of palliation matters.
Gordon, Blanca; (...); Subira, Laura Dos
Article. 10.1016/j.rec.2023.03.001. 2024
Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support.
Ezzitouny M; (...); Martínez-Dolz L
Article. 10.3390/jpm11111122. 2021